Table 1 Patient demographic and clinical characteristics.
Characteristic | Sarcopenia (n = 34) (No, %; Mean ± SD) | Non-sarcopenia (n = 37) (No, %; Mean ± SD) | p value |
|---|---|---|---|
Gender | 0.973 | ||
Male | 21 (61.8%) | 23 (62.2%) | |
Female | 13 (38.2%) | 14 (37.8%) | |
Age (years) | 55.5 ± 9.73 | 56.7 ± 11.1 | 0.630 |
Height (m) | 1.64 ± 0.08 | 1.65 ± 0.09 | 0.805 |
ECOG performance | 0.377 | ||
0 | 13 (38.2%) | 18 (48.6%) | |
1 | 21 (61.8%) | 19 (51.4%) | |
Primary site | 0.904 | ||
Rectum | 17(50.0%) | 17(45.9%) | |
Left colon | 11(32.4%) | 12(32.4%) | |
Right colon | 6(17.6%) | 8(21.6%) | |
Synchronous metastases | 0.439 | ||
Yes | 15 (44.1%) | 13 (35.1%) | |
No | 19 (55.9%) | 24 (64.9%) | |
Location of liver metastases | 0.590 | ||
Bilobar | 30 (88.2%) | 31 (83.8%) | |
Unilobar | 4 (11.8%) | 6 (16.2%) | |
Largest lesion (cm) | 4.9 ± 3.3 | 4.1 ± 2.7 | 0.260 |
Extrahepatic metastases | 0.600 | ||
Yes | 14 (41.2%) | 13 (35.1%) | |
No | 20 (58.8%) | 24 (64.9%) | |
NLR | 5.5 ± 3.1 | 4.2 ± 2.7 | 0.059 |
SMA (cm2) | 100.1 ± 12.6 | 125.7 ± 19.7 | < 0.001 |
SMI (cm2/m2) | 36.8 ± 3.0 | 45.9 ± 5.1 | < 0.001 |
